Aetna, Partners Unite to Bolster Direct Care Workforce in IL, LA, NC
Aetna, National Alliance for Care at Home, and MissionCare Collective Partner to Strengthen the Direct Care Workforce in Illinois, Louisiana, and North Carolina In a bold and strategic move to…
AstraZeneca to Unveil Latest Respiratory Research at ATS 2025
AstraZeneca Unveils Expansive Respiratory Portfolio and Pioneering Clinical Data at ATS 2025 to Advance Care Across Asthma, COPD, and Inflammatory Lung Diseases AstraZeneca is poised to make a significant impact…
Merck to Present Novel Oncology Advances and Pipeline Data at ASCO 2025
Merck to Unveil Broad Range of Clinical Advances Across 25+ Cancer Types at ASCO 2025 Merck (NYSE: MRK), known as MSD outside the United States and Canada, is set to…
TVC Partners with Norbrook to Bring Felanorm™ to Independent Veterinary Practices
TVC Partners with Norbrook to Bring Felanorm™ to Independent Veterinary Practices The Veterinary Cooperative (TVC), the premier group purchasing organization dedicated to supporting independent veterinary practices across the United States,…
Orca Bio Unveils New Leadership Team Changes
Orca Bio Unveils New Leadership Team Changes Orca Bio, a late-stage biotechnology company dedicated to transforming the treatment landscape for patients through its cutting-edge high-precision cell therapies, has announced an…
Feinstein Institutes Study Vagus Nerve Stimulation for Obesity
Feinstein Institutes Study Vagus Nerve Stimulation for Obesity Obesity is one of the most pressing health challenges facing the modern world, with over a third of the global population affected…
Innate Pharma Announces First Quarter 2025 Financial Results and Business Highlights
Innate Pharma Announces First Quarter 2025 Financial Results and Business Highlights Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA), a clinical-stage oncology-focused biotechnology company pioneering innovative immunotherapies, announced its consolidated…
Ten-Year Data Perjeta Regimen Cuts Death Risk by 17% in HER2+ Breast Cancer
Ten-Year Data Perjeta Regimen Cuts Death Risk by 17% in HER2+ Breast Cancer In a significant milestone for the treatment of early-stage HER2-positive breast cancer, Genentech, a member of the…
Azafaros Raises €132M in Series B to Advance Phase 3 LSD Therapies
Azafaros Raises €132M in Series B to Advance Phase 3 LSD Therapies Azafaros, a clinical-stage biotechnology company with a specialized focus on rare lysosomal storage disorders (LSDs), announced the successful…
InnoCare’s Mesutoclax Granted Breakthrough Therapy Designation by China’s NMPA
InnoCare’s Mesutoclax Granted Breakthrough Therapy Designation by China’s NMPA In a landmark development for China’s oncology therapeutics landscape, InnoCare Pharma Limited (HKEX: 09969; SSE: 688428), a biopharmaceutical company recognized for…
Hansoh Pharma’s Ameile Approved for Fourth Use in EGFR+ NSCLC Adjuvant Therapy
Hansoh Pharma’s Ameile Gains Approval for New Indication in Early-Stage EGFR-Mutant NSCLC Hansoh Pharmaceutical Group Co., Ltd (03692.HK), hereafter referred to as Hansoh Pharma, announced that its innovative product Ameile…
Icotrokinra Shows Strong Results in Hard-to-Treat Scalp and Genital Psoriasis
Johnson & Johnson (NYSE: JNJ) today announced promising new results from the Phase 3 ICONIC-TOTAL study evaluating icotrokinra (JNJ-2113), a first-in-class investigational targeted oral peptide designed to selectively block the…